dorsaVi Seeks ASX Quotation for 80 Million New Shares

dorsaVi Limited ( (AU:DVL) ) has issued an announcement.

dorsaVi Ltd has applied for quotation on the ASX of 80 million new ordinary fully paid shares under its existing ticker DVL. The securities, issued on 27 February 2026, arise from transactions previously notified to the market, expanding the company’s quoted share capital and potentially broadening its investor base.

The move formalises the listing of these additional shares and reflects ongoing capital management activity by dorsaVi within the Australian equity market. The enlarged quoted float may improve trading liquidity and visibility on the ASX, with implications for existing shareholders through potential dilution alongside enhanced market access for the company.

The most recent analyst rating on (AU:DVL) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on dorsaVi Limited stock, see the AU:DVL Stock Forecast page.

More about dorsaVi Limited

dorsaVi Ltd is an Australian-listed company trading on the ASX under the code DVL. The firm operates in the technology and medical/biomechanics space, though this filing focuses chiefly on its capital markets activity rather than detailing its products or core services.

Average Trading Volume: 1,457,257

Technical Sentiment Signal: Sell

Current Market Cap: A$32.77M

For detailed information about DVL stock, go to TipRanks’ Stock Analysis page.